AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionLee Financial Co
Latest Disclosed Ownership8,784 shares
Latest Disclosed Value $ 1,910,341
Lee Financial Co reports 19.64% decrease in ownership of 4AB / AbbVie Inc.

On April 13, 2026 - Lee Financial Co filed a 13F-HR form disclosing ownership of 8,784 shares of AbbVie Inc. (BG:4AB) valued at $1,910,341 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 10,931 shares of AbbVie Inc.. This represents a change in shares of -19.64% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F ABBVIE COM 00287Y109 8,784 -2,147 -19.64 1,910 -23.51 0.2543
2026-01-22 2025-12-31 13F ABBVIE COM 00287Y109 10,931 -1,621 -12.91 2,498 -14.07 0.3370
2025-11-04 2025-09-30 13F ABBVIE COM 00287Y109 12,552 228 1.85 2,906 27.07 0.3644
2025-07-24 2025-06-30 13F ABBVIE COM 00287Y109 12,324 464 3.91 2,288 -7.93 0.3281
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 11,860 -1,554 -11.58 2,485 4.24 0.3796
2025-01-30 2024-12-31 13F ABBVIE COM 00287Y109 13,414 -210 -1.54 2,384 -11.41 0.3347
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 13,624 1,379 11.26 2,690 28.10 0.3821
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 12,245 -599 -4.66 2,100 -10.18 0.3422
2024-05-15 2024-03-31 13F ABBVIE COM 00287Y109 12,844 -128 -0.99 2,339 16.32 0.3900
2024-02-08 2023-12-31 13F ABBVIE COM 00287Y109 12,972 -106 -0.81 2,010 3.13 0.3527
2023-11-09 2023-09-30 13F ABBVIE COM 00287Y109 13,078 -885 -6.34 1,949 3.62 0.3632
2023-08-08 2023-06-30 13F ABBVIE COM 00287Y109 13,963 -1,295 -8.49 1,881 -22.62 0.3295
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 15,258 -1,482 -8.85 2,432 -10.13 0.4172
2023-02-09 2022-12-31 13F ABBVIE COM 00287Y109 16,740 168 1.01 2,705 21.63 0.4616
2022-11-02 2022-09-30 13F ABBVIE COM 00287Y109 16,572 317 1.95 2,224 -10.65 0.4159
2022-08-10 2022-06-30 13F ABBVIE COM 00287Y109 16,255 -638 -3.78 2,489 -9.09 0.4566
2022-05-11 2022-03-31 13F ABBVIE COM 00287Y109 16,893 -1,734 -9.31 2,738 8.56 0.4900
2022-02-08 2021-12-31 13F ABBVIE COM 00287Y109 18,627 -125 -0.67 2,522 24.67 0.4737
2021-11-12 2021-09-30 13F ABBVIE COM 00287Y109 18,752 307 1.66 2,023 -2.65 0.4185
2021-08-04 2021-06-30 13F ABBVIE COM 00287Y109 18,445 -340 -1.81 2,078 2.21 0.4407
2021-05-13 2021-03-31 13F ABBVIE COM 00287Y109 18,785 -342 -1.79 2,033 -0.83 0.4820
2021-02-12 2020-12-31 13F ABBVIE COM 00287Y109 19,127 106 0.56 2,050 23.05 0.5317
2020-11-03 2020-09-30 13F ABBVIE COM 00287Y109 19,021 257 1.37 1,666 -9.55 0.4655
2020-08-11 2020-06-30 13F ABBVIE COM 00287Y109 18,764 -147 -0.78 1,842 27.83 0.5113
2020-05-07 2020-03-31 13F ABBVIE COM 00287Y109 18,911 -66 -0.35 1,441 -14.23 0.4780
2020-02-14 2019-12-31 13F ABBVIE COM 00287Y109 18,977 -5 -0.03 1,680 16.91 0.3629
2019-11-08 2019-09-30 13F ABBVIE COM 00287Y109 18,982 2,801 17.31 1,437 22.09 0.3232
2019-07-30 2019-06-30 13F ABBVIE COM 00287Y109 16,181 -60 -0.37 1,177 -10.08 0.2658
2019-04-30 2019-03-31 13F ABBVIE COM 00287Y109 16,241 161 1.00 1,309 -11.67 0.3064
2019-02-11 2018-12-31 13F ABBVIE COM 00287Y109 16,080 -276 -1.69 1,482 -4.14 0.3972
2018-11-07 2018-09-30 13F ABBVIE COM 00287Y109 16,356 -174 -1.05 1,546 0.91 0.3801
2018-08-14 2018-06-30 13F ABBVIE COM 00287Y109 16,530 -454 -2.67 1,532 -4.73 0.3611
2018-05-09 2018-03-31 13F ABBVIE COM 00287Y109 16,984 -2,225 -11.58 1,608 -13.41 0.4080
2018-02-09 2017-12-31 13F ABBVIE COM 00287Y109 19,209 -395 -2.01 1,857 6.60 0.5395
2017-11-07 2017-09-30 13F ABBVIE COM 00287Y109 19,604 -2,386 -10.85 1,742 9.22 0.5621
2017-07-27 2017-06-30 13F ABBVIE COM 00287Y109 21,990 3,872 21.37 1,595 35.17 0.5871
2017-05-09 2017-03-31 13F ABBVIE COM 00287Y109 18,118 -561 -3.00 1,180 0.94 0.4703
2017-02-14 2016-12-31 13F ABBVIE COM 00287Y109 18,679 18,679 1,169 0.6544
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.